Chuck Royce's GILD Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 42,500 shares of Gilead Sciences, Inc. (GILD) worth $5.22 M, representing 0.05% of the portfolio. First purchased in 2020-Q4, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in GILD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 35,500 shares. Largest reduction occurred in Q4 2021, reducing 54,500 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2020 | +20,000 | New Buy | 20,000 | $58.25 |
| Q1 2021 | +35,500 | Add 177.50% | 55,500 | $64.63 |
| Q2 2021 | +500 | Add 0.90% | 56,000 | $68.86 |
| Q3 2021 | -1,500 | Reduce 2.68% | 54,500 | $69.85 |
| Q4 2021 | -54,500 | Sold Out | 0 | $0.00 |
| Q1 2022 | +22,000 | New Buy | 22,000 | $59.45 |
| Q2 2022 | +5,000 | Add 22.73% | 27,000 | $61.81 |
| Q1 2023 | +12,000 | Add 44.44% | 39,000 | $82.97 |
| Q2 2023 | +14,500 | Add 37.18% | 53,500 | $77.07 |
| Q3 2023 | +4,500 | Add 8.41% | 58,000 | $74.94 |
| Q1 2024 | +3,000 | Add 5.17% | 61,000 | $73.25 |
| Q2 2024 | +19,000 | Add 31.15% | 80,000 | $68.61 |
| Q4 2024 | -10,000 | Reduce 12.50% | 70,000 | $92.37 |
| Q1 2025 | -2,000 | Reduce 2.86% | 68,000 | $112.05 |
| Q2 2025 | -19,000 | Reduce 27.94% | 49,000 | $110.87 |
| Q3 2025 | -6,500 | Reduce 13.27% | 42,500 | $111.00 |
Chuck Royce's Gilead Sciences Investment FAQs
Chuck Royce first purchased Gilead Sciences, Inc. (GILD) in Q4 2020, acquiring 20,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Gilead Sciences, Inc. (GILD) for 21 quarters since Q4 2020.
Chuck Royce's largest addition to Gilead Sciences, Inc. (GILD) was in Q1 2021, adding 55,500 shares worth $3.59 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 42,500 shares of Gilead Sciences, Inc. (GILD), valued at approximately $5.22 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.05% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Gilead Sciences, Inc. (GILD) was 80,000 shares, as reported at the end of Q2 2024.